drugset / Trial / NCT00055666

Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract

NCT00055666

Completed 51 enrolled Roswell Park Cancer Institute
Non-randomizedOpen-labelSupportive care

Summary

RATIONALE: Beclomethasone may be effective in treating patients who have graft-versus-host disease of the gastrointestinal tract. PURPOSE: Compassionate use of beclomethasone in treating patients who have graft-versus-host disease of the gastrointestinal tract that has not responded to previous therapy.

Timeline

Start
2001-03
Primary completion
2005-02
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject beclomethasone dipropionate Other / unclassified Oral